Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

1disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: stage IVA2 SS ×

stage IVA2 SS

This disease is selected. Its supporting articles are shown below.

stage IVA2 SS1

Articles mentioning stage IVA2 SS

1 articles · page 1 of 1

5PSQ-057 Case report: combination therapy with mogamulizumab and DA-EPOCH chemotherapy in refractory sézary syndrome

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

84.0%

cutaneous T-cell lymphoma Sézary syndrome (SS)stage IVA2 SS refractory SS mogamulizumab methotrexate doxorubicin Lancet Oncol aprepitant

…L, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma. Lancet Oncol. 2018;19(9):1192–1204.Conflict of Interest No con…

Browse diseases

stage IVA2 SS

Articles mentioning stage IVA2 SS

5PSQ-057 Case report: combination therapy with mogamulizumab and DA-EPOCH chemotherapy in refractory sézary syndrome